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Molecular characteristics of the Goodpasture autoantigen. Goodpas-
ture syndrome is an autoimmune disease causing rapidly progressive
glomerulonephritis and pulmonary hemorrhage. The clinical manifesta-
tions are caused by autoantibodies that bind to a constituent, termed the
Goodpasture autoantigen, of alveolar and glomerular basement mem-
branes. Searches for the identity of this constituent have recently
culminated in the discovery of two new chains (cr3 and cr4) of type IV
collagen and the identification of the cr3 chain as the Goodpasture
autoantigen. The gene, COL4A3, encoding this autoantigen was re-
cently cloned and localized to the q35-37 region of chromosome 2. The
major protomeric form of the cr3 chain is a homotrimer. The cr3-
protomers associate through NCI-to-NC1 interactions mainly with each
other to form a suprastructure, although some associate with protomers
containing the al(IV) and cr2(IV) chains. The cr3-protomers also form
suprastructures involving triple helical interactions of three or more
protomers. The Goodpasture epitope is localized to the carboxyl-
terminal region of the a3(IV) chain, encompassing the last 36 residues
of the chain, as the primary interaction site, and its structure is
discontinuous.
Goodpasture syndrome, named after Ernest Goodpasture
who first described its clinical features in 1919 [1], is an
autoimmune disease causing rapidly progressive glomerulone-
phritis and pulmonary hemorrhage [2]. The clinical manifesta-
tions range from massive pulmonary hemorrhage with little
overt evidence of renal disease to fulminant crescentic glomer-
ulonephritis with no evidence of pulmonary hemorrhage. The
pulmonary hemorrhage and glomerulonephritis are caused by
autoantibodies that bind to a constituent, termed the Goodpas-
ture autoantigen, of alveolar and glomerular basement mem-
branes.
Searches for the identity of this constituent have culminated
in the discovery of two new chains (cr3 and cr4) of type IV
collagen. The a3(IV) chain was identified as the Goodpasture
autoantigen [3—8] and its gene COL4A3, was recently cloned
and its chromosomal location determined (Fig. 1) [9, 10]. A fifth
chain (a5) of type IV collagen was recently discovered by
molecular cloning [11, 12]. This article presents an overview of
the structure of type IV collagen and the Goodpasture autoan-
tigen, and the location and structure of the Goodpasture
epitope.
Structure of type IV collagen
Type IV collagen is the major constituent of mammalian
basement membranes, such as the renal glomerular basement
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membrane depicted in Figure 2A. This component exists as a
supramolecular structure (Fig. 2B) and serves as a scaffold for
the binding and alignment of other macromolecular constitu-
ents, that is, laminin, heparan sulfate proteoglycan, and entac-
tin [13—17].
The suprastructure of type IV collagen is comprised of
protomers (building block units) that are linked to one another
through end-to-end interactions. The protomer (Fig. 2C) is
composed of three a chains and it is characterized by three
structural domains: 7S at the amino terminus; triple helical in
the middle region; and NC! (noncollagenous) domain at the
carboxyl terminus [13, 14, 18]. Protomers associate in a head-
to-head (NC 1-to-NC I) fashion to form dimers and in a tail-to-
tail (7S-to-7S) fashion to form tetramers (Fig. 2B). The classical
protomer is composed of two a! chains and one cr2 chain, and
the chains are comprised of 1669 and 1707 amino acid residues,
respectively [19, 20].
Other kinds of protomers, differing in chain composition, also
exist as three other chains of type IV collagen [a3(IV), a4(IV),
and a5(IV)] have been discovered. The initial evidence for
existence of the a3 and a4 chains was derived from physico-
chemical and immunochemical studies of the NC 1 domain
(hexamer) of type IV collagen that had been excised from lens
and glomerular basement membranes by collagenase digestion
[3—6, 21]. The existence of the cr3 chain was recently verified by
molecular cloning of a cDNA that encodes the a3NCl domain
and a portion of the a3 triple-helical domain [9, 10]. Molecular
cloning of cr4 chain, encoding the NC1 domain and a portion of
the triple helix has been recently accomplished [22]. The a5
chain of type IV collagen was also recently discovered by
recombinant DNA technology [11, 12].
The co-expression of five chains in a basement membrane
allows for as many as 35 possible protomer subtypes [22]. The
predominant one is the classical protomer comprised of two al
and one a2 chain. The composition of protomers containing the
newly discovered chains is largely unknown and the protomers
may be homotrimers or heterotrimers. Protomers containing the
cr3 chain, appear to be mainly homotrimers (vide infra) [5—7, 23].
The existence of several protomer subtypes implies that at
least two and up to 630 different combinations of protomer-
protomer (NC1-to-NC1) associations occur [22]. The combina-
tions are in two groups: the association of protomers of like
subtype forming homodimers, and the association of protomers
of different subtypes forming heterodimers. The available evi-
dence suggests that protomer-protomer (Nd-NC!) associa-
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tions are mainly between like subtypes [5—7, 23]. The specificity
of protomer associations at the 7S domain is unknown, but it is
presumed that those containing the a3, a4, and aS chains
associate to form tetramers analogous to those containing the
a! and a2 chains.
Structure of the Goodpasture autoantigen
The a3(IV) chain of type IV collagen was recently established
as the Goodpasture autoantigen (Fig. 2 C and D). The identity
was established through extensive studies of the molecular and
immunochemical properties of the soluble form of the antigen
that was obtained by collagenase digestion of alveolar, glomer-
ular, and lens basement membranes [3—8]. The existence of the
chain was recently verified by molecular cloning of a cDNA that
encodes the NC! domain (235 residues) and a segment (228
residues) of the triple-helical domain [9, 10]. The chain is
presumed to contain about 1600 to 1700 amino acids analogous
to the at, a2 and a5 chains, and based on 1460 residues found
in a truncated form of the chain [23]. The gene, COL4A3,
encoding this chain was recently localized to q35-37 region of
chromosome 2 (Fig. 1).
The major protomeric form of the a3 chain is a homotrimer
[5, 6, 23]. The a3-protomers associate through NC1-to-NC1
interactions mainly with each other forming a suprastructure
(Fig. 2B) [5—7, 23], although some associate with classical
protomers. The a3-protomers also form suprastructures involv-
ing triple-helical interactions of three or more protomers [23].
At their 7S domain, they are presumed to form tetramers
analogous to that established for classical protomers.
Location and structure of the Goodpasture epitope
The Goodpasture epitope, the combining site for the patho-
genic autoantibodies, was recently localized to the carboxyl-
terminus of the NC! domain of the a3(IV) chain (Fig. 2 D and
E) [24]. The evidence includes: a distinctive hydrophilic amino
acid sequence, as found by comparing the homologous NC!
domains of the five known a chains of type IV collagen; the
identification of lysine and cystine as critical residues for
antibody binding, as shown through the use of selective chem-
ical modifications; and the identification of this region as critical
for antibody binding, as shown through the use of synthetic
peptides. The findings strongly indicate that the epitope is
localized to the carboxyl-terminal region of a3NC 1, encom-
passing residues 198-233 as the primary interaction site, and
that its structure is discontinuous and stabilized by disulfide
bonds.
The structural relationship of the carboxyl-terminal region to
other parts of the NC! domain, as imposed by disulfide bonds,
is presented in Figure 3. The pairing of disulfide bonds in
a3NC! is assumed to be identical to that of alNCl and a2NC1
[25] because the 12 cysteine residues occur in identical loca-
tions in each case. The arrangement illustrated in model I brings
all six lysine residues into close proximity, five in region
198-233 and one in the adjacent loop A'. Potentially, unique
residues in other regions may contribute to the complete
epitope. As illustrated in model II, disuffide bonds may stabilize
a specific conformation of region 198-233, juxtaposing specific
residues at the amino and carboxyl termini of this region to form
a discontinuous epitope.
A discontinuous epitope also provides a possible explanation
for the cryptic properties of the Goodpasture epitope [26]. The
hexameric form of a3NC 1 binds Goodpasture antibody to a
limited extent, but upon dissociation of hexamer into monomer
and dimer subunits, antibody binding greatly increases, reflect-
ing a sequestered epitope. Conceivably, antibody binding to
hexamer reflects binding to a portion of a discontinuous epitope
or a complete epitope that is exposed on the hexamer surface,
whereas the increased binding to hexamer subunits reflects
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Fig. 2. Schematic illustration of the
molecular structure of type IV collagen and
the Goodpasture autoantigen of renal
glomerular basement membrane. (A) The
glomerular basement membrane (GBM) is
positioned between epithelial and endothelial
cells. Type IV collagen is the target for the
pathogenic autoantibodies in patients with
Goodpasture syndrome. (B) Type IV collagen,
the major constituent of GBM exists as a
supramolecular network. The dark area
denotes collagen triple helical molecules
containing the a3(IV) chain, the Goodpasture
autoantigen. The a3 protomers are presumed
to form 7S domains, analogous to al and a2
protomers. The light area denotes the triple
helical collagen molecules that do not contain
the a3(IV) chain (Goodpasture autoantigen).
The globular domain of collagen IV is shown
as a circle. Antibody localization is shown by
an arrow. (C) The collagen IV molecule at the
protomer level with three a chains, composing
of one or more of the five kinds of chains, in
a triple helical conformation with carboxyl
terminal globular domains. The a3(IV) chain
is shown in dark [evidence suggests presence
of a3 homodimers [61] with its globular
domain (NC1 domain) shown binding the
autoantibody at its hypothetical binding site
shown in white. 7S domain is shown at the
N-terminal side. (D) shows the a3(IV) NCI
chain, the Goodpasture autoantigen in its
entirety and (E) represents the detailed
molecular structure of the NC I domain with
the intra-chain disulfide pairings and the
primary interaction site for the autoantibodies
(white area) [24]. Each dot represents an
amino acid residue.
exposure of the complete discontinuous epitope or to another
complete epitope. Exposure of an epitope by an event such as
infection or exposure to organic solvents may play an important
role in the initial production of the pathogenic autoantibodies
causing Goodpasture syndrome.
Conclusions and perspectives
Searches for the molecular identity of the Goodpasture
autoantigen of alveolar and glomerular basement membranes
have culminated in the discovery of two new chains of type IV
collagen, and the identification of the a3(IV) chain as the
Goodpasture autoantigen. Molecular cloning of the gene encod-
ing this antigen provided the basis for localizing the antibody
combining-site to the carboxyl-terminus of the NC! domain.
Many important questions remain unanswered about the mo-
lecular structure, organization, assembly, and function of this
autoantigen, and about its role in the etiology of Goodpasture
syndrome.
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Fig. 3. Composite diagrams depicting the location of the primary interaction site of the GP epitope, region 198-233, within a3(IV)NCI monomer.
Region 198-233 (SLNPERMFRKPIPSTVKAGELEKIISRCQVCMKKRH) of a3NC1 is designated by the shaded area. The location of region
198-233 is presented in the context of discontinuous regions that are held in juxtaposition by disulfide bonds. The disulfide bonds, marked by short
white bars, are arranged as they occur in cslNCl and a2NC1 [251. For clarity only one of two possible disulfide configurations is shown. The
diagram also depicts the conserved (filled circles) and variable regions (open circles) among the five NC1 domains (aI-a5) as previously described
[24]. Models I and II depict different folding patterns of region 198-233 of loop C' and the analogous region of loop C. In model II, region 198-23 3
is folded to juxtapose its carboxyl- and amino-termini.
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